Replies to post #428201 on ORIONS Money Stocks

[rayank]

YES "Akebia Therapeutics Q3 EPS $(0.46) Misses $(0.43) Estimate, Sales $91.98M Miss $99.38M Estimate
8:00 am ET November 12, 2019 (Benzinga)

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.43) by 6.98 percent. This is a 23.33 percent increase over losses of $(0.6) per share from the same period last year. The company reported quarterly sales of $91.98 million which missed the analyst consensus estimate of $99.38 million by 7.45 percent. This is a 73.00 percent increase over sales of $53.169 million the same period last year."

8:53 am ET

*Akebia Reports Secured $100M Non-Dilutive Term Loan Financing(Benzinga)